Epstein Secrets

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 nglmL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 nglmL NA-FUBIM 0.20 ng/mL Rot. Limit Compound Rot. Limit NMS v.18.0 EFTA00130085 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER

hat will be reported as being positive. If the compound is listed as None Detected, It Is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present. Acode 9560B - Synthetic Cannabinoids Screen (2019 Scope),

-PINACA 5-fluoro- EMB-PINACA 5-fluoro-MMB-PINACA 5-fluoro-NA-PIC 5-fluoro-QU-PINAC ADAMANTYL-FUBINACA ADMB-CHMINACA ADMB-FUBICA ADMB-FUBINACA AMB-CHMINACA Rot Limit 0.10 ng/mL 0.10 ng/mL 0.10 ng/mL 0.10 ng/mL 0.20 ng/mL 0.050 ng/rra. 0.10 ng/mL 0.10 ng/mL 0.20 ng/mL 0.10 ng/mL 1.0 ng/mL 1.0

d that will be reported as being positive. If the compound is Wad as None Detected, it is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 9560B - Synthetic Cernabinoids Screen (2019 Scope),

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 rig/mt. MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA•FUBIM 0.20 ng/mL NMS v.18.0 EFTA00063528 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMB

at will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting LM'iit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present. Acode 9560B - Synthetic Cannabinotds Screen (2019 Scope),

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1 0 ng/mL ADMB-FUBICA 1.0 ngIrrL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 020 ng/mL NMS v.18.0 EFTA00049624 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBE

hat will be reported as being positive. If the compound is fisted as None Detected, it is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 9560B - Synthetic Carnabinoids Screen (2019 Scope),

L ADMB-CHMINACA 0.10 ng/ml MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/ml ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/ml AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/ml NMSv.18.0 Page 3243 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBER:

that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 9560B- Synthetic Cannabinaids Screen (2019 Scope), B

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/mL NMS v.18.0 EFTA00133089 EFTA00133090 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY RE

that will be reported as being positive. If the compound Is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 95608 - Synthetic Cannabinoids Screen (2019 Scope),